• Explore /
  • Poster
  • / Efficacy of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with wild-type KRAS exon2 metastatic colorectal cancer previously treated with bevacizumab within 6 months.

Efficacy of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with wild-type KRAS exon2 metastatic colorectal cancer previously treated with bevacizumab within 6 months.

Abstract Poster

Authors

null

Kaori Hayashi

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Kaori Hayashi , Seiichiro Mitani , Hiroya Taniguchi , Satoshi Hamauchi , Keiji Sugiyama , Takahiro Tsushima , Kazunori Honda , Akiko Todaka , Toshiki Masuishi , Tomoya Yokota , Yukiya Narita , Nozomu Machida , Shigenori Kadowaki , Akira Fukutomi , Takashi Ura , Yusuke Onozawa , Masashi Ando , Hirofumi Yasui , Kei Muro , Kentaro Yamazaki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 800)

DOI

10.1200/JCO.2017.35.4_suppl.800

Abstract #

800

Poster Bd #

N22

Abstract Disclosures

Similar Posters

First Author: David Chan

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Effectiveness of biologic agents among Hispanics in the US with metastatic colorectal cancer.

Effectiveness of biologic agents among Hispanics in the US with metastatic colorectal cancer.

First Author: Riya Jayesh Patel

First Author: Hironaga Satake

First Author: Heinz-Josef Lenz